LYCA NASDAQ
Lycia Therapeutics Inc.
YTD: -3.8%
$27.18
-1.68 (-5.81%)
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.5B
52W Range22.19-36.49
Volume965,385
Avg Volume2,287,202
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAetna Wun Trombley
Employees65
SectorHealthcare
IndustryBiotechnology
IPO Date2026-10-23
Websitelyciatx.com
400 East Jamie Court
South San Francisco, CA 94080
US
South San Francisco, CA 94080
US
About Lycia Therapeutics Inc.
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
Latest News
At a glance: stocks gapping down premarket
Lycia Therapeutics (LYCA) Stock Price, News & Analysis $LYCA - MarketBeat
Lycia Therapeutics (LYCA) Jumps After IPO With Valuation Questions Now Front And Center - Yahoo Finance
Lycia Therapeutics, Inc. (LYCA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lycia Therapeutics, Inc. Common Stock (LYCA) insider ownership and holdings – Yahoo Finance - Yahoo Finance Singapore
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fischer Laurent | A-Award | 20,000 | $18.00 | 2026-10-22 |
| Henderson Jane | A-Award | 20,000 | $18.00 | 2026-10-22 |
| RIEFLIN WILLIAM JL | A-Award | 20,000 | $18.00 | 2026-10-22 |
| ELI LILLY & Co | 0 | — | 2026-10-22 | |
| Fischer Laurent | A-Award | 13,307 | $3.70 | 2026-08-11 |